The most common research areas linked to Epithalon include longevity studies, cellular aging research, telomere research, sleep-related aging pathways, immune function studies, and overall cellular health investigations
Sealed vials have lower internal pressure than the outside environment
We may recommend diagnostic tests to assess your overall health and identify any underlying conditions that could benefit from peptide therapy
The standard retatrutide dose schedule is: Weeks 1-4: 1 mg once weekly Weeks 5-8: 2 mg once weekly Weeks 9-12: 4 mg once weekly Weeks 13-16: 8 mg once weekly Week 17 onward: 8-12 mg once weekly (maintenance) In the combination context, many researchers find that 8 mg is sufficient for their maintenance dose rather than pushing to 12 mg, because the cagrilintide provides enough additional appetite suppression and satiety to make the extra 4 mg of retatrutide unnecessary
Female pattern hair loss often has hormonal drivers thyroid dysfunction, estrogen decline, elevated androgens that a DUTCH hormone panel can identify